Global Med Technologies(R), Inc. Appeals Court Decision
2005年4月2日 - 3:04AM
PRニュース・ワイアー (英語)
Global Med Technologies(R), Inc. Appeals Court Decision DENVER,
April 1 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med") is vigorously
pursuing an appeal of the summary judgment and the award of
attorney's fees of approximately $655,000 rendered in the Donnie L.
Jackson lawsuit. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global
Med believes that the lower court ruling in this case is
substantively and procedurally in error and does not believe that
this lawsuit will have a material impact on Global Med's business.
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health, medical information technology
company, providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Current clients of Wyndgate's products and services manage
more than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Saharan Africa. Together, the
SafeTrace Tx advanced transfusion management system and the
SafeTrace(R) donor management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. Statements
in this press release that are not strictly historical are
"forward-looking" statements within the meaning of the Safe Harbor
provisions of the federal securities laws. Forward-looking
statements involve risks and uncertainties, including, but not
limited to, continued acceptance of the Company's products and
services in the marketplace, regulatory and competitive factors,
new products and technological changes, the Company's dependence
upon third-party suppliers, and other risks detailed from time to
time in the Company's Form 10-K and other regularly filed reports.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., Chairman and CEO of Global
Med Technologies(R), Inc., +1-303-238-2000; or Investor Relations,
John Nesbett or Jordan Silverstein, both of The Investor Relations
Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site:
http://www.globalmedtech.com/
Copyright